New weight loss drugs could be developed much faster if Roche gets its wayByBruce GilPublishedSeptember 30, 2024
Costco, Hims, Noom, and more: 6 companies that started hawking weight loss products this yearByBruce GilPublishedSeptember 30, 2024
WeightWatchers is struggling in the weight loss drug era — and now the CEO is outByBruce GilPublishedSeptember 27, 2024
The FDA just approved Bristol Myers Squibb's groundbreaking schizophrenia treatmentByBruce GilPublishedSeptember 27, 2024
A weight loss drug developer's stock soars after a $198 million IPOByBruce GilPublishedSeptember 26, 2024
The Boar's Head listeria outbreak has been linked to a 10th death. Lawmakers want answersByBruce GilPublishedSeptember 26, 2024
Disney+ is following Netflix in cracking down on password sharingByBruce GilUpdatedSeptember 26, 2024
Now playing BioAge Labs wants to raise $200 million in IPO to develop obesity and diabetes drugsPublishedSeptember 25, 2024
Novo Nordisk's CEO took the Washington hot seat over Ozempic prices. 3 takeaways from his testimonyByBruce GilPublishedSeptember 24, 2024
Blame drug 'middlemen' for Ozempic and Wegovy prices, Novo Nordisk CEO tells CongressByBruce GilUpdatedSeptember 24, 2024
Novo Nordisk is bigger than Denmark's economy — but the prime minister isn't worried about another NokiaByBruce GilUpdatedSeptember 23, 2024
Novo Nordisk's experimental weight loss pill has some concerning side effectsByBruce GilUpdatedSeptember 20, 2024
Bridgerton, Berlin, and more: The 10 most-watched shows on Netflix so far this yearByBruce GilPublishedSeptember 20, 2024
People watched a whopping 94 billion hours of Netflix in the first half of 2024, CEO saysByBruce GilPublishedSeptember 18, 2024
